Omnicomm Systems Inc (OMCM) 0.2150 $OMCM
OmniComm Systems, Inc. Reports Financial Results for the Quarter Ended June 30, 2016
GlobeNewswire - Mon Aug 15, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm"
(OTCQX:OMCM), a global leading provider of clinical data management technology, today announced its financial results for the quarter ended June 30, 2016.
Medical Product Stock Earnings Coming Up: IMMY, OMCM, CLRB
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 6:50AM CDT
For the rest of the season, earnings are anticipated to grow 4.7%, driven by impressive top-line growth expectation of 7.7% in Medical sector.
CLRB: 2.34 (-0.01), IMMY: 3.91 (+0.09)
Global Top 15 Pharma Company Signs 3 Year Agreement for OmniComm Systems' TrialOne(R)
GlobeNewswire - Thu Aug 04, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that a global top 15 pharmaceutical organization selected TrialOne to automate its entire Phase I and BA/ BE clinic. The expressed aims are to standardize processes, improve business intelligence, ensure compliance, and achieve overall business transformation within its early phase research.
OmniComm Systems Signs Multi-Million Dollar, Five Year Agreement with Top 5 US Medical Research University
GlobeNewswire - Tue Aug 02, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster(R) EDC and related services to conduct a series of clinical studies over a five year period.
OmniComm Systems' Inaugural European Innovation Forum a Major Success
GlobeNewswire - Thu May 19, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm" (OTCQX:OMCM), a global leading provider of clinical data management technology, held its inaugural European customer summit. The two day event provided a forum for OmniComm customers to network, share current innovations, best practices and demonstrate the transformative impact of OmniComm's technology on clinical development and research. The Innovation Forum was held at the Centre of Human Drug Research, co-located with OmniComm Systems' office in Leiden, The Netherlands.
OmniComm Systems, Inc. Reports Financial Results for the Quarter Ended March 31, 2016
GlobeNewswire - Tue May 17, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm" (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced its financial results for the quarter ended March 31, 2016.
OmniComm Systems Signs Five-Year, Multi-Million Dollar TrialMaster EDC Agreement with CROMSOURCE
GlobeNewswire - Tue Apr 26, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced the signing of a five-year, multi-million dollar agreement with CROMSOURCE, a leading contract research organization (CRO), headquartered in Verona, Italy, with offices throughout Europe and North America. OmniComm's TrialMaster electronic data capture (EDC) suite will be used for the collection of clinical data during this five-year term in trials spanning all clinical phases and numerous therapeutic areas.
OmniComm Systems Penetrates Growing Israeli Life Sciences Market
GlobeNewswire - Mon Apr 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced the signing an agreement with Medistat Ltd., a leading data management and biostatistics organization, headquartered in Tel Aviv, Israel. OmniComm's TrialMaster electronic data capture (EDC) suite will be used to address the clinical trial needs of the growing Israeli life sciences sector which consists of more than 1300 organizations.
OmniComm Systems, Inc. Reports Financial Results for the Year Ended December 31, 2015
GlobeNewswire - Thu Mar 31, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today reported financial results for the year ended December 31, 2015.
OmniComm Systems(R) to Present EHR to EDC eSource Strategies at eClinical Forum Webinar
GlobeNewswire - Tue Feb 09, 7:15AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global provider of clinical data capture technology, announced that it will present at the eClinical Forum "Birds of a Feather" webinar on the topic of "eSource Strategies Between Electronic Health Records (EHR) and Electronic Data Capture (EDC)". The presentation will focus on industry drivers for EDC to EHR integration, and review feedback from a recent eSource market survey conducted by OmniComm. OmniComm will also provide a proof-of-concept demonstration on how data can be pulled from an EHR system into the TrialMaster(R) EDC technology.
OmniComm Systems' TrialMaster(R) EDC Technology Enables Global Biopharmaceutical Company to Streamline Clinical Development Time and Increase Product Success
Marketwired - Mon Dec 28, 7:00AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced the expanded use and adoption of TrialMaster electronic data capture (EDC) by a leading global biopharmaceutical company across its entire pipeline of drug candidates. In 2015 this biopharmaceutical company used TrialMaster to run 23 clinical trials. Since selecting TrialMaster the company has run more than 65 clinical studies across 1,300 investigational sites recruiting more than 3,000 trial volunteers.
OmniComm Systems Achieves Major Milestone With Over 1,500 Active TrialOne Users Worldwide
Marketwire Canada - Wed Dec 16, 7:00AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announces major milestone achievements for TrialOne. TrialOne is used in a variety of clinics, supporting both healthy and patient driven early phase studies across a multitude of therapeutic areas and study types. Within one year TrialOne has been deployed in early phase clinics that account for over 1,100 beds, 1,500 users and over 470 clinical studies annually.
OmniComm Systems(R) Named as a Top 10 Clinical Data Management Solution Provider
Marketwired - Thu Dec 10, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced its inclusion as one of the top 10 clinical data management solution providers in 2015 by Pharma Tech Outlook. Pharma Tech Outlook has chosen OmniComm Systems as one of the Top 10 Clinical Data Management Solution Providers of 2015. The positioning is based upon an evaluation of OmniComm's capabilities in providing the market with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments.
Omnicell's (OMCL) Battles Escalating Costs: Should You Dump?
Zacks Equity Research - Zacks Investment Research - Mon Dec 07, 2:55PM CST
On Dec 7, 2015, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 13.03 (+0.30), OMCL: 38.03 (+0.57), ATHN: 122.89 (+0.80)
3 Reasons Value Stock Investors Will Love OmniComm Systems (OMCM)
Zacks Equity Research - Zacks Investment Research - Fri Dec 04, 7:43AM CST
OmniComm Systems (OMCM) is an impressive stock as it has a strong Value Score, favorable Zacks Rank and is also seeing positive estimate revisions.
OmniComm Systems Announces Results of eSource Survey: Industry Leaders See Increasing Role of Technology to Transform Clinical Development
Marketwired - Thu Dec 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announced the results of an industry wide survey to understand the challenges facing sponsors and contract research organizations (CROs) in their quest for efficient data collection. The majority of the respondents were from sponsors (biopharmaceutical organizations) and CROs, 42% and 32% respectively. At least half of respondents indicated that more than 50% of site source records are still maintained on paper.
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
Zacks Equity Research - Zacks Investment Research - Wed Nov 25, 8:30AM CST
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
AIRM: 34.54 (+0.46), GILD: 78.17 (-1.60), MYL: 43.22 (+0.19)
OmniComm Systems, Inc. Reports Financial Results for the Quarter Ended June 30, 2016
GlobeNewswire - Mon Aug 15, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm"
(OTCQX:OMCM), a global leading provider of clinical data management technology, today announced its financial results for the quarter ended June 30, 2016. Medical Product Stock Earnings Coming Up: IMMY, OMCM, CLRB
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 6:50AM CDT
For the rest of the season, earnings are anticipated to grow 4.7%, driven by impressive top-line growth expectation of 7.7% in Medical sector.
CLRB: 2.34 (-0.01), IMMY: 3.91 (+0.09)
Global Top 15 Pharma Company Signs 3 Year Agreement for OmniComm Systems' TrialOne(R)
GlobeNewswire - Thu Aug 04, 7:02AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that a global top 15 pharmaceutical organization selected TrialOne to automate its entire Phase I and BA/ BE clinic. The expressed aims are to standardize processes, improve business intelligence, ensure compliance, and achieve overall business transformation within its early phase research.
OmniComm Systems Signs Multi-Million Dollar, Five Year Agreement with Top 5 US Medical Research University
GlobeNewswire - Tue Aug 02, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced that one of the top 5 medical research universities in the US, selected OmniComm TrialMaster(R) EDC and related services to conduct a series of clinical studies over a five year period.
OmniComm Systems' Inaugural European Innovation Forum a Major Success
GlobeNewswire - Thu May 19, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm"
(OTCQX:OMCM), a global leading provider of clinical data management technology, held its inaugural European customer summit. The two day event provided a forum for OmniComm customers to network, share current innovations, best practices and demonstrate the transformative impact of OmniComm's technology on clinical development and research. The Innovation Forum was held at the Centre of Human Drug Research, co-located with OmniComm Systems' office in Leiden, The Netherlands. OmniComm Systems, Inc. Reports Financial Results for the Quarter Ended March 31, 2016
GlobeNewswire - Tue May 17, 7:00AM CDT
OmniComm Systems, Inc. ("OmniComm"
(OTCQX:OMCM), a global leading provider of clinical data management technology, today announced its financial results for the quarter ended March 31, 2016. OmniComm Systems Signs Five-Year, Multi-Million Dollar TrialMaster EDC Agreement with CROMSOURCE
GlobeNewswire - Tue Apr 26, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced the signing of a five-year, multi-million dollar agreement with CROMSOURCE, a leading contract research organization (CRO), headquartered in Verona, Italy, with offices throughout Europe and North America. OmniComm's TrialMaster electronic data capture (EDC) suite will be used for the collection of clinical data during this five-year term in trials spanning all clinical phases and numerous therapeutic areas.
OmniComm Systems Penetrates Growing Israeli Life Sciences Market
GlobeNewswire - Mon Apr 11, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today announced the signing an agreement with Medistat Ltd., a leading data management and biostatistics organization, headquartered in Tel Aviv, Israel. OmniComm's TrialMaster electronic data capture (EDC) suite will be used to address the clinical trial needs of the growing Israeli life sciences sector which consists of more than 1300 organizations.
OmniComm Systems, Inc. Reports Financial Results for the Year Ended December 31, 2015
GlobeNewswire - Thu Mar 31, 7:00AM CDT
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global leading provider of clinical data management technology, today reported financial results for the year ended December 31, 2015.
OmniComm Systems(R) to Present EHR to EDC eSource Strategies at eClinical Forum Webinar
GlobeNewswire - Tue Feb 09, 7:15AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX:OMCM), a global provider of clinical data capture technology, announced that it will present at the eClinical Forum "Birds of a Feather" webinar on the topic of "eSource Strategies Between Electronic Health Records (EHR) and Electronic Data Capture (EDC)". The presentation will focus on industry drivers for EDC to EHR integration, and review feedback from a recent eSource market survey conducted by OmniComm. OmniComm will also provide a proof-of-concept demonstration on how data can be pulled from an EHR system into the TrialMaster(R) EDC technology.
OmniComm Systems' TrialMaster(R) EDC Technology Enables Global Biopharmaceutical Company to Streamline Clinical Development Time and Increase Product Success
Marketwired - Mon Dec 28, 7:00AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced the expanded use and adoption of TrialMaster electronic data capture (EDC) by a leading global biopharmaceutical company across its entire pipeline of drug candidates. In 2015 this biopharmaceutical company used TrialMaster to run 23 clinical trials. Since selecting TrialMaster the company has run more than 65 clinical studies across 1,300 investigational sites recruiting more than 3,000 trial volunteers.
OmniComm Systems Achieves Major Milestone With Over 1,500 Active TrialOne Users Worldwide
Marketwire Canada - Wed Dec 16, 7:00AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announces major milestone achievements for TrialOne. TrialOne is used in a variety of clinics, supporting both healthy and patient driven early phase studies across a multitude of therapeutic areas and study types. Within one year TrialOne has been deployed in early phase clinics that account for over 1,100 beds, 1,500 users and over 470 clinical studies annually.
OmniComm Systems(R) Named as a Top 10 Clinical Data Management Solution Provider
Marketwired - Thu Dec 10, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, today announced its inclusion as one of the top 10 clinical data management solution providers in 2015 by Pharma Tech Outlook. Pharma Tech Outlook has chosen OmniComm Systems as one of the Top 10 Clinical Data Management Solution Providers of 2015. The positioning is based upon an evaluation of OmniComm's capabilities in providing the market with a choice of best-of-breed EDC platforms that are purpose-built for their unique clinical research environments.
Omnicell's (OMCL) Battles Escalating Costs: Should You Dump?
Zacks Equity Research - Zacks Investment Research - Mon Dec 07, 2:55PM CST
On Dec 7, 2015, we issued an updated research report on Omnicell, Inc. (OMCL).
MDRX: 13.03 (+0.30), OMCL: 38.03 (+0.57), ATHN: 122.89 (+0.80)
3 Reasons Value Stock Investors Will Love OmniComm Systems (OMCM)
Zacks Equity Research - Zacks Investment Research - Fri Dec 04, 7:43AM CST
OmniComm Systems (OMCM) is an impressive stock as it has a strong Value Score, favorable Zacks Rank and is also seeing positive estimate revisions.
OmniComm Systems Announces Results of eSource Survey: Industry Leaders See Increasing Role of Technology to Transform Clinical Development
Marketwired - Thu Dec 03, 7:01AM CST
OmniComm Systems, Inc. (OmniComm) (OTCQX: OMCM), a global leading provider of clinical data management technology, announced the results of an industry wide survey to understand the challenges facing sponsors and contract research organizations (CROs) in their quest for efficient data collection. The majority of the respondents were from sponsors (biopharmaceutical organizations) and CROs, 42% and 32% respectively. At least half of respondents indicated that more than 50% of site source records are still maintained on paper.
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
Zacks Equity Research - Zacks Investment Research - Wed Nov 25, 8:30AM CST
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
AIRM: 34.54 (+0.46), GILD: 78.17 (-1.60), MYL: 43.22 (+0.19)
